Results 131 to 140 of about 6,302,624 (294)
Published to accompany the exhibition held at 200 Gertrude Street, June ...
200 Gertrude Street (Gallery)
core
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
Catalogue of an exhibition held at 200 Gertrude Street, Fitzroy, Vic., 4 - 26 Sept ...
200 Gertrude Street (Gallery)
core
Αθήνα 200 χρόνια 200 κτίρια - Athens 200 years 200 buildings, Συλλογικό έργο
openaire +2 more sources
ADP‐ribosylation: An emerging regulator of the epigenome
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho +2 more
wiley +1 more source
Transparencies : recent paintings and objects from Adelaide
Catalogue of an exhibition held at 200 Gertrude Street, Fitzroy, Victoria, 24 Aug.-13 Sept.
200 Gertrude Street (Gallery)
core
Unraveling the epigenetic code in cancer cell–tumor microenvironment crosstalk
Epigenetic regulation is a key driver of cancer development and progression. Diverse epigenetic alterations in cancer cells and components of the tumor microenvironment (TME) orchestrate their communication through multiple mechanisms. We discuss how the epigenetic code coordinates bidirectional cancer cell–TME crosstalk to promote cancer progression ...
Ji Hoon Park, Mi‐Young Kim
wiley +1 more source
Published to accompany the exhibition "Redline 7000", held at 200 Gertrude Street, Friday 4-Saturday 26 May ...
200 Gertrude Street (Gallery)
core
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source
Catalogue of an exhibition held at 200 Gertrude Street, Fitzroy, Victoria. Essay by Stephen O'connell.
200 Gertrude Street (Gallery)
core

